logo

For the Inventor, By the Inventor

Gyeonggi-do, South Korea

Qurient Co., Ltd.


USPTO Granted Patents = 9


Trademarks = 1

Forward Citations = 28

Loading Chart...
Loading Chart...

39 inventors (with patents filed for the assignee):

goldMedal Jaeseung Kim (8 out of 18 patents)

silverMedal Kiyean Nam (7 out of 12 patents)

bronzeMedal Yeejin Jeon (5 out of 8 patents)

4.  Dongsik Park (5 out of 9 patents)

5.  SaeYeon Lee (4 out of 7 patents)

6.  Jeongjun Kim (3 out of 3 patents)

7.  Mooyoung Seo (3 out of 8 patents)

8.  Seohyun Ahn (2 out of 2 patents)

9.  Doohyung Lee (2 out of 2 patents)

10.  Young-In Yang (2 out of 2 patents)

11.  Jiye Ahn (2 out of 2 patents)

12.  Hana Kim (2 out of 20 patents)

13.  Sangchul Lee (2 out of 12 patents)

14.  Ki Yean Nam (2 out of 2 patents)

15.  Sae Yeon Lee (2 out of 2 patents)


9 patents:

1. 12410165 - Different forms of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide (2025-09-09),
2. 12162858 - Quinoline derivatives as inhibitors of AXL/MER RTK and CSF1R (2024-12-10),
3. 11945822 - Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase (2024-04-02),
4. 11858937 - Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors (2024-01-02),
5. 11447486 - 2-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitors (2022-09-20),
6. 10934274 - Quinoline derivatives as TAM RTK inhibitors (2021-03-02),
7. 9855243 - Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation (2018-01-02),
8. 9655841 - Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation (2017-05-23),
9. 9029389 - Anti-inflammation compounds (2015-05-12),
Company Overview
Qurient Co., Ltd. is a leading biopharmaceutical company in South Korea focused on developing innovative therapeutics for unmet medical needs. With a strong pipeline of drug candidates targeting various diseases including cancer, autoimmune disorders, and infectious diseases, Qurient is committed to improving patients' lives through cutting-edge research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#77 in Gyeonggi-do

#1,188 in South Korea

Gyeonggi-do, KR
Gyeonggi-do, South Korea

Qurient Co., Ltd.

Forward Citations = 28

39 inventors:

goldMedal Jaeseung Kim (8 out of 18 patents)

silverMedal Kiyean Nam (7 out of 12 patents)

bronzeMedal Yeejin Jeon (5 out of 8 patents)

4.  Dongsik Park (5 out of 9 patents)

5.  SaeYeon Lee (4 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Qurient Co., Ltd.. Retrieved from https://idiyas.com/company/qurient-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…